US Stock MarketDetailed Quotes
UBX Unity Biotechnology
- 1.2500
- +0.0400+3.31%
Trading Nov 29 10:00 ET
21.06MMarket Cap-976P/E (TTM)
1.2500High1.2200Low8.44KVolume1.2200Open1.2100Pre Close10.36KTurnover0.06%Turnover RatioLossP/E (Static)16.85MShares2.020052wk High1.49P/B18.32MFloat Cap1.105052wk Low--Dividend TTM14.66MShs Float245.6000Historical High--Div YieldTTM2.48%Amplitude1.1050Historical Low1.2280Avg Price1Lot Size
About Unity Biotechnology Company
Unity Biotechnology, Inc. operates as a biotechnology company. The firm is developing a portfolio of programs like biological mechanisms implicated in diseases of aging, and also senolytic programs in ophthalmologic and neurologic disorders. The company was founded by Nathaniel Eames David, Jan van Deursen, Judith Campisi, and Daohong Zhou on March 30, 2009 and is headquartered in South San Francisco, CA.
Company Profile
SymbolUBX
Company NameUnity Biotechnology
Listing DateMay 3, 2018
Issue Price17.00
Founded2009
CEODr. Anirvan Ghosh, PhD
MarketNASDAQ
Employees19
Fiscal Year Ends12-31
Address285 East Grand Avenue
CitySouth San Francisco
ProvinceCalifornia
CountryUnited States of America
Zip Code94080
Phone1-650-416-1192
Company Executives
- Name
- Position
- Salary
- Dr. Anirvan Ghosh, PhD
- Director and Chief Executive Officer
- 2.03M
- Lynne Sullivan
- Chief Financial Officer, Principal Accounting Officer and Head of Corporate Development
- 1.08M
- Keith R. Leonard, Jr
- Chairman of the Board
- 80.75K
- Dr. Nathaniel E. David, PhD
- Director
- 50.75K
- Paul L. Berns
- Lead Independent Director
- 88.25K
- Dr. Gilmore O’Neill, M.B.
- Independent Director
- 55.75K
- Camille D. Samuels
- Independent Director
- 61.25K
- Michael P. Samar
- Independent Director
- 60.93K
- Dr. Margo R. Roberts, PhD.
- Independent Director
- 54.75K
- Alexander Hieu Nguyen, J.D.
- General Counsel and Corporate Secretary
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data